Magzter GOLD ile Sınırsız Olun

Magzter GOLD ile Sınırsız Olun

Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin

$149.99
 
$74.99/Yıl

Denemek ALTIN - Özgür

Eco-conscious packaging: A strategic opportunity

Express Pharma

|

December 2024

Larger pharma companies are applying sustainable practices and eco-conscious materials to packaging and labelling, leading to positive environmental outcomes, increasing operational efficiency and improving consumer perception. But wooing environmentally-conscious consumers often needs a sizeable capex, which could be a hurdle for pharma MSMEs. Viveka Roychowdhury reports that MSMEs can maximise this strategic opportunity once they identify areas which can improve efficiency through optimisation and harmonisation, at reasonable costs

- Viveka Roychowdhury

Eco-conscious packaging: A strategic opportunity

For patients, medicines are the difference between life and death, a good day or a painful one. But the onus of delivering on this promise rests on the product pack.

Ironically, the part of the product most important to ensuring its worth is worthless and even considered an ecological burden after its job is done.

The impact of packaging is felt only when it does not do its job and therefore pharmaceutical companies have traditionally invested quite a bit on product packs, also using them as part of their branding strategy.

But with increasing pressure on pharma companies to reduce their carbon footprint, the fundamentals of pharma product packaging are being re-written.

As per a Future Market Insights report, the global sustainable pharma packaging market size is projected to grow from US$ 96 billion in 2024 to US$ 410 billion by 2034, reflecting a 15.6 per cent CAGR.

The report titled, Sustainable Pharmaceutical Packaging Market Outlook (2024 to 2034), lists trends like switching to renewably sourced compostable materials which spontaneously decompose into organic molecules, decreasing waste and having a minimal negative environmental impact.

The rise of robotics and automation integration in packaging processes and developing modular and reconfigurable packaging solutions are also mentioned in the report as are trends like investigations into edible pharmaceutical packaging materials derived from natural substances as a sustainable alternative.

Shivshankar S.R, CEO, ACG Packaging Materials says that pharma companies can look at a number of measures to reduce their carbon footprint, which could include using single polymer plastic when it comes to packaging materials and reducing overall packaging size.

Express Pharma'den DAHA FAZLA HİKAYE

Express Pharma

Express Pharma

Flexotherm Heating Tapes & Cords

Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling

time to read

1 mins

October 2025

Express Pharma

Express Pharma

DRIVING INDIA'S INNOVATION EDGE

Pharma leaders come together to highlight Bengaluru's R&D strength, tech ecosystem, and talent pool to power India Pharma Inc's shift from generics to innovation and global leadership

time to read

16 mins

October 2025

Express Pharma

Express Pharma

Al compass: Transforming pharma commercialisation

As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging Al across nearly every aspect of commercialisation, from market forecasting and personalised marketing to dynamic pricing and beyond. In this article, Neha Aathavale takes the pulse of the industry to explore who is taking note and how companies are beginning to put Al into action in their commercial operations

time to read

7 mins

October 2025

Express Pharma

Express Pharma

PRIME NEO: New age doors from Gandhi Automation

Gandhi Automations presents the multi-composites, high-performance door PRIME NEO for clean environments. Complete Washable, Greater Sealing and Pressure Resistant.

time to read

1 mins

October 2025

Express Pharma

Express Pharma

Unani Medicine: At crossroads of tradition and modernity

Manufacturers, academic institutions and research councils are working together to elevate Unani medicine through clinical validation and policy alignment with international standards, finds Swati Rana

time to read

7 mins

October 2025

Express Pharma

Express Pharma

Single-Use Technologies in Biologics Manufacturing: Benefits, Challenges, and Growing Demand

The biopharmaceutical industry is increasingly adopting single-use technology (SUT) to achieve flexibility, cost efficiency, and faster time-to-market. Compared with stainless steel systems, SUT reduces capital investment, eliminates cleaning and sterilization steps, lowers contamination risk, and shortens production timelines.

time to read

1 min

October 2025

Express Pharma

Express Pharma

Sustainable packaging with Romaco and Liveo Research

Recycable blister packs

time to read

3 mins

October 2025

Express Pharma

Express Pharma

With India soon to be three times the population of the EU, it makes perfect sense to have manufacturing here

As part of Sweden's Focus Asia programme, a high-level SME delegation recently visited India to strengthen bilateral ties and explore collaborations across sectors including pharma, biotech and others. Building on the momentum of the \"Time for Sweden\" event, the visit underscored Sweden's commitment to innovation, sustainability, and co-creation with India. Among the delegation was Emil Alexander Byström, CEO of SpinChem AB, who in an interaction with Kalyani Sharma shared his insights on how advanced Swedish technologies like biocatalysis and the company's patented Rotating Bed Reactor (RBR) can accelerate India's pharma and biotech innovation journey while supporting sustainable growth.

time to read

3 mins

October 2025

Express Pharma

Express Pharma

Cell therapy's next chapter: Industry embraces in-vivo innovation

Nikhil C Bhanumathi, Principal Clinical Lead, Thermo Fisher Scientific highlights that cell therapy is entering a bold new phase in 2025 as the industry shifts from complex, lab-based ex vivo CAR-T to faster, more accessible in vivo CAR-T innovations. This approach promises to expand access, lower costs, and potentially tackle solid tumors and autoimmune diseases

time to read

4 mins

October 2025

Express Pharma

Express Pharma

Research misconduct ...can delay meaningful and reliable discoveries

Dr Gráinne McNamara, Research Integrity/Publication Ethics Manager, S. Karger AG explores how research misconduct, peer review fraud slow down pharma research. Of particular concern to India is the fact that India-based researchers constitute 5 per cent of articles in life sciences retracted between 1976-2023. India-based researchers also have one of the highest rates of retraction relative to the overall publication output. Over an email exchange with Viveka Roychowdhury, she details how publishers are now deploying AI tools, some of which contributed to the problem in the first place, to detect and avert fraudulent research submissions

time to read

6 mins

October 2025

Listen

Translate

Share

-
+

Change font size